HSD17B4 and myeloid sarcoma: Our results confirm a recent study by Roczkowsky and colleagues, reporting reduced expression of the β-oxidation gene HSD17B4 and other peroxisomal genes in normal-appearing white matter from MS patients vs. other disease controls [20].